Dr. Hönle AG (HNL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Dr. Hönle AG (HNL) has a cash flow conversion efficiency ratio of -0.001x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-48.00K ≈ $-56.12K USD) by net assets (€75.69 Million ≈ $88.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HNL cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Dr. Hönle AG - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Dr. Hönle AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Dr. Hönle AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Dr. Hönle AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Thai Wacoal Public Company Limited
BK:WACOAL
|
-0.002x |
|
News Network Corporation Public Company Limited
BK:NEWS
|
-0.007x |
|
Herantis Pharma Oyj
HE:HRTIS
|
-1.937x |
|
Montebalito S.A.
MC:MTB
|
0.012x |
|
Anadolu Isuzu Otomotiv Sanayi ve Ticaret AS
IS:ASUZU
|
0.351x |
|
BTCS Inc
NASDAQ:BTCS
|
-0.011x |
|
HLV LIMITED
NSE:HLVLTD
|
0.007x |
|
TAFI Industries Bhd
KLSE:7211
|
-0.045x |
Annual Cash Flow Conversion Efficiency for Dr. Hönle AG (2014–2025)
The table below shows the annual cash flow conversion efficiency of Dr. Hönle AG from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see HNL market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | €77.03 Million ≈ $90.06 Million |
€4.99 Million ≈ $5.83 Million |
0.065x | -6.73% |
| 2024-09-30 | €79.69 Million ≈ $93.16 Million |
€5.53 Million ≈ $6.47 Million |
0.069x | +112.26% |
| 2023-09-30 | €96.13 Million ≈ $112.39 Million |
€3.14 Million ≈ $3.67 Million |
0.033x | +147.34% |
| 2022-09-30 | €107.24 Million ≈ $125.37 Million |
€-7.41 Million ≈ $-8.66 Million |
-0.069x | -779.14% |
| 2021-09-30 | €111.12 Million ≈ $129.91 Million |
€1.13 Million ≈ $1.32 Million |
0.010x | -83.60% |
| 2020-09-30 | €116.69 Million ≈ $136.42 Million |
€7.23 Million ≈ $8.46 Million |
0.062x | -66.99% |
| 2019-09-30 | €90.12 Million ≈ $105.36 Million |
€16.92 Million ≈ $19.79 Million |
0.188x | -32.34% |
| 2018-09-30 | €87.25 Million ≈ $102.00 Million |
€24.22 Million ≈ $28.31 Million |
0.278x | +194.37% |
| 2017-09-30 | €69.78 Million ≈ $81.58 Million |
€6.58 Million ≈ $7.69 Million |
0.094x | -32.66% |
| 2016-09-30 | €61.67 Million ≈ $72.10 Million |
€8.63 Million ≈ $10.09 Million |
0.140x | -12.08% |
| 2015-09-30 | €57.51 Million ≈ $67.24 Million |
€9.16 Million ≈ $10.71 Million |
0.159x | +5.68% |
| 2014-09-30 | €49.72 Million ≈ $58.13 Million |
€7.49 Million ≈ $8.76 Million |
0.151x | -- |
About Dr. Hönle AG
Hoenle AG develops, manufactures, and distributes industrial UV technologies and systems in Germany and internationally. It operates through three segments: Adhesive Systems, Curing, and Disinfection. The Adhesives Systems segment offers industrial adhesives, as well as supplies adhesive curing systems used for consumer electronics, automotive, optics and opto-electronics, and curing of adhesives… Read more